© Francois Guenet / Inserm
Appointed by the French Council of Ministers on November 26, 2018, Gilles Bloch took up his post as Chairman and Chief Executive Officer of Inserm on January 2, 2019.
A graduate of the École Polytechnique, doctor, and researcher specializing in medical imaging, Gilles Bloch spent a large part of his career at the French Atomic Energy Commission before taking on major roles within research policy, including heading up the French National Research Agency upon its creation, and then being appointed Head of Research and Innovation at the Ministry of Higher Education and Research. Since 2015, he has chaired Université Paris-Saclay.
On the occasion of his new role, Gilles Bloch will present his New Year greetings to the press on Tuesday January 15, 2019 at 9 a.m., at Inserm headquarters.
Press contact and registration: email@example.com
Furthering scientific knowledge knows no frontiers. Therefore, Inserm would like to reaffirm that the countries of Africa are – more than ever – key scientific partners ...
Inserm Research Director Alain Eychène is taking the helm at the French National Cancer Institute’s Research and Innovation division. In this new role, he will also head the Aviesan Multi-Organization Institute (ITMO) for cancer and will manage Inserm’s Cancer institute. ...